CopyMark Law Group
4.9/5
Drawing for ESSERRE

USPTO serial 79365506

ESSERRE

Reviewed by CopyMark Law Group

Reg. 7435507Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
ATTANG, UDEME U
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ESSERRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Larry H. Tronco

Larry H. Tronco Holland & Hart, LLPPO Box 8749Trademark DocketingDenver, CO 80201

Goods and services

ClassDescriptionStatusFirst use
001Chemical and organic compositions in the nature of fruit extracts and nutraceuticals for the manufacture of food and drink; Chemical substances, chemical materials and preparations, and natural elements being fruit extracts and nutraceuticals for use in the manufacture of food supplements and cosmetics; Chemical compounds and materials for use in science, namely, reagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Chemicals for use in the manufacture of pharmaceuticals; Plant extracts for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; chemicals for use in the manufacture of food supplements; Plant extracts for use in the manufacture of food supplements; plant extracts for use in the food industry, namely, plant extracts in the manufacture of foods; plant extracts for use in the manufacture of cosmetics; Botanical extracts, other than essential oils, for use in the manufacture of cosmeticsACTIVE—
005Pharmaceutical and natural medicines for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergy, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headache, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, trauma; Food supplements and dietary preparations being dietary supplements for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergy, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headache, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, trauma; Pharmaceutical products, namely, skin lotions and dermatological preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 5, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 18, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 18, 2024FIMPFINAL DISPOSITION PROCESSED—
Oct 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 2, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 15, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 15, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 9, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 9, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 9, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 3, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 3, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 21, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2023DOCKASSIGNED TO EXAMINER—
Mar 24, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance